De Bono, Johann S. Pantel, Klaus Efstathiou, Eleni and Sternberg, Cora N. Castellano, Daniel Fizazi, Karim Tombal, Bertrand Wulfing, Christian Schonhoft, Joseph D. Gill, Audrey Chu, Lincy Wenstrup, Rick Ozatilgan, Ayse and Geffriaud-Ricouard, Christine Mace, Sandrine De Wit, Ronald, CTC counts as a biomarker of prognosis and response in metastatic
castration-resistant prostate cancer (mCRPC) from the CARD trial., World Journal of Clinical Oncology, (39), 2021, Lippincott, Williams & Wilkins,